245 related articles for article (PubMed ID: 12061944)
21. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
22. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.
Vender RL; Mauger D; Walsh S; Alam S; Simmons Z
Amyotroph Lateral Scler; 2007 Feb; 8(1):36-41. PubMed ID: 17364434
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with survival in the National Registry of Veterans with ALS.
Pastula DM; Coffman CJ; Allen KD; Oddone EZ; Kasarskis EJ; Lindquist JH; Morgenlander JC; Norman BB; Rozear MP; Sams LA; Sabet A; Bedlack RS
Amyotroph Lateral Scler; 2009; 10(5-6):332-8. PubMed ID: 19922120
[TBL] [Abstract][Full Text] [Related]
24. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
Sívori M; Rodríguez GE; Pascansky D; Sáenz C; Sica RE
Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.
Nalini A; Thennarasu K; Gourie-Devi M; Shenoy S; Kulshreshtha D
J Neurol Sci; 2008 Sep; 272(1-2):60-70. PubMed ID: 18550082
[TBL] [Abstract][Full Text] [Related]
26. An observational study of cognitive impairment in amyotrophic lateral sclerosis.
Rippon GA; Scarmeas N; Gordon PH; Murphy PL; Albert SM; Mitsumoto H; Marder K; Rowland LP; Stern Y
Arch Neurol; 2006 Mar; 63(3):345-52. PubMed ID: 16533961
[TBL] [Abstract][Full Text] [Related]
27. The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy.
Georgoulopoulou E; Fini N; Vinceti M; Monelli M; Vacondio P; Bianconi G; Sola P; Nichelli P; Mandrioli J
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):338-45. PubMed ID: 23373475
[TBL] [Abstract][Full Text] [Related]
28. Early use of non-invasive ventilation prolongs survival in subjects with ALS.
Lechtzin N; Scott Y; Busse AM; Clawson LL; Kimball R; Wiener CM
Amyotroph Lateral Scler; 2007 Jun; 8(3):185-8. PubMed ID: 17538782
[TBL] [Abstract][Full Text] [Related]
29. ALS clinical trials: do enrolled patients accurately represent the ALS population?
Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G;
Neurology; 2011 Oct; 77(15):1432-7. PubMed ID: 21956723
[TBL] [Abstract][Full Text] [Related]
30. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis.
Drory VE; Bronipolsky T; Artamonov I; Nefussy B
J Neurol Sci; 2008 Oct; 273(1-2):81-3. PubMed ID: 18678378
[TBL] [Abstract][Full Text] [Related]
31. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
Peysson S; Vandenberghe N; Philit F; Vial C; Petitjean T; Bouhour F; Bayle JY; Broussolle E
Eur Neurol; 2008; 59(3-4):164-71. PubMed ID: 18230874
[TBL] [Abstract][Full Text] [Related]
32. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
Murphy M; Quinn S; Young J; Parkin P; Taylor B
Neurology; 2008 Dec; 71(23):1889-95. PubMed ID: 19047561
[TBL] [Abstract][Full Text] [Related]
33. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
34. Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not gold.
Armon C; Guiloff RJ; Bedlack R
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):109-12. PubMed ID: 12495570
[TBL] [Abstract][Full Text] [Related]
35. Natural history of young-adult amyotrophic lateral sclerosis.
Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
[TBL] [Abstract][Full Text] [Related]
36. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
[TBL] [Abstract][Full Text] [Related]
37. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
Dib M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
[TBL] [Abstract][Full Text] [Related]
38. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
[TBL] [Abstract][Full Text] [Related]
39. The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS).
Vardeny O; Bromberg MB
J Herb Pharmacother; 2005; 5(3):23-31. PubMed ID: 16520295
[TBL] [Abstract][Full Text] [Related]
40. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
